Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 76   

Articles published

ARNA 4.12 -0.02 (-0.48%)
price chart
Morning Stock Alert: Arena Pharmaceuticals, Inc. (ARNA), Occidental Petroleum ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) of the Healthcare sector has a change from open of - 0.240% since the opening bell today with a volume of 334,007 shares.
Related articles »  
Belviq For Smoking Cessation - Sizzle Or Smolder? (ARNA)
Belviq, from Arena Pharmaceuticals (NASDAQ:ARNA) was recently involved in an early clinical trial as a possible aid to smoking cessation.
Related articles »  
Will Belviq Advertising Pick Up Again?
The month of October has passed, and with that it is time to update on what has been happening on the advertising front with Belviq from Arena (NASDAQ:ARNA). Eight weeks ago the advertising for Belviq began running at a very impressive rate. Over the ...
Lorcaserin HCl Data to be Presented at the Annual Meeting of the American ...
Related articles »  
Eisai Earnings Give Arena Investors Insights (ARNA)
Additional revenue for Arena can come from manufacturing services, other Eisai collaborative revenue, and the sale of Taigen stock that the company still holds. I anticipate that manufacturing revenue will be between $500,000 and $700,000. I anticipate ...
Stocks Worth Adding To Your Watchlist: Alpha Pro Tech, Ltd. (APT), Arena ...  Markets Emerging
Lorcaserin Data to be Presented at The Obesity Society's Annual ...  MarketWatch
Related articles »  
Will Arena Pharma (ARNA) Q3 Loss Be Wider than Expected?
Arena Pharmaceuticals, Inc. (ARNA - Snapshot Report) is scheduled to report its third-quarter 2014 results before the opening bell on Nov 3. Last quarter, the company had posted a negative earnings surprise of 9.09%.
Will Arena Pharma (ARNA) Q3 Loss Be Wider than Expected? - Analyst Blog  Nasdaq
Related articles »  
Biotech Stocks in Concerns: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Arena ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) [Trend Analysis] reported that the US Patent and Trademark Office decided Arena U.S.
Valeant Pharmaceuticals (NYSE:VRX) announces FDA approval of ONEXTON ...  Property Mentor
Related articles »  
Trader's Buzz: Unilife Corporation (UNIS), Arena Pharmaceuticals (ARNA ...
Arena Pharmaceuticals, Inc. (ARNA) today announced positive top-line results of a pilot study to assess the safety of lorcaserin HCl and phentermine HCl.
Mid Day Movers: CSX Corp. (CSX), Arena Pharmaceuticals, Inc. (ARNA), FMC ...
Arena Pharmaceuticals, Inc. (ARNA) of the Healthcare sector (Biotechnology) has lost -0.85% from open per share at mid-day today.
Special News Alert: Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Arena ...
Lakeway, NY - (MARKET NEWS CALL) - 11/26/2014�, an investment community with a special focus on updating investors with recent news on the U.S.
Closing Bell Day In Review: Arena Pharmaceuticals, Inc. (ARNA), Edison ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) of the Healthcare sector changed by 0.00% today, a change from open of 0.24% per share with a volume of 2,875,465.